Pharmacotherapeutic interventions for cocaine abuse: Present practices and future directions

Journal of Addictive Diseases

Volumn 10, Issue 4, 1991, Pages 13-30

  Crosby, Ross D ^a   Halikas, James A ^b   Carlson, Gregory A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CARBAMAZEPINE; COCAINE; DOPAMINE; FLUPENTIXOL; METHADONE; METHYLPHENIDATE; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

DRUG ABUSE; HUMAN; NAUSEA; REVIEW; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CARBAMAZEPINE; COCAINE; DOPAMINE AGENTS; HUMAN; RECURRENCE; SEROTONIN ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0025872060     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v10n04_02     Document Type: Article

References (102)

1. National Institute on Dru g Abuse: Proceedings of Community Epidemiology Work Group. NIDA Division of Epidemiology and Prevention, June, 1989.
2. Adams, E.H. & Kozel, N.J. Cocaine use in America: Introduction and overview. In E.H. Adams & N.J. Kozel (Eds.), Cocaine Use in America: Epidemiologic and Clinical Perspectives. National Institute of Drug Abuse Research Monograph Series, 1985, 61:35-49.
3. Kleber, H.D. & Gawin, F. The spectrum of cocaine use and its treatment. Journal of Clinical Psychiatry, 1984, 45(12): 18-23.
4. Schnoll, S.H., Karrigan, J., Kitchen, S.B., Daghestani, A. & Hansen, T. Characteristics of cocaine abusers presenting for treatment. In E.H. Adams & N.J. Kozel (Eds.), Cocaine Use in America: Epidemiologic and Clinical Perspectives. NIDA Research Monograph Series, 1985, 61: 171-181.
5. Dackis, C.A., Gold, M.S. & Sweeney, D.R. The physiology of cocaine craving and “crashing.” Archives of General Psychiatry, 1987, 44:298-299.
6. Dackis, C.A., Gold, M.S., Sweeney, D.R., Byron, J.P. & Climko, R. Single-dose bromocriptine reverses cocaine craving. Psychiatry Research, 1987, 20: 261-264.
7. Grinspoon, L. & Bakalar, J.B. Drug dependence: Non-narcotic agents. In H.I. Kaplan, A.M. Freedman & B.J. Sadock (Eds.), Comprehensive Textbook of Psychiatry, 3rd Edition, Baltimore: Williams & Wilkins, 1980.
8. Gawin, F.H. & Kleber, H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: Clinical observations. Archives of General Psychiatry, 1986, 41: 107-113.
9. Dackis, C.A. & Gold, M.S. Psychopharmacology of cocaine. Psychiatric Annals, 1988, 18(9):528-530.
10. Gawin, F.H. Chronic neuropharmacology of cocaine: Progress in pharmacotherapy. Journal of Clinical Psychiatry, 1988, 49 (2 suppl.), 11-16.
11. Kosten, T.R. Pharmacotherapeutic interventions for cocaine abuse. Journal of Nervous and Mental Disease, 1989 (7), 177:379-389.
12. Dackis, C.A. & Gold, MS. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neuroscience and Biobehavioral Reviews, 1985, 9: 469-477.
13. Wyatt, R.J., Karoum, F., Suddath, R. & Hitri, A. The role of dopamine in cocaine use and abuse. Psychiatric Annals, 1988, 18(9), 528-530.
14. Dackis, C.A. & Gold, M.S. Bromocriptine as a treatment for cocaine abuse. Lancet, 1985, 1: 1151-1152.
15. Extein, I.L., Gross, D.A. & Gold, M.S. Bromocriptine treatment of cocaine withdrawal symptoms (letter). American Journal of Psychiatry, 1989, 146(3):403.
16. Kosten, R.T. Schumann, B. & Wright, D. Bromocriptine treatment of cocaine abuse in methadone maintained patients (letter). American Journal of Psychiatry, 1988, 145: 381-382.
17. Extein, I.E. & Gold, M.S. The treatment of cocaine addicts: Bromocriptine or desipramine? Psychiatric Annals, 1988, 18(9):535-537.
18. Giannini, A.J., Baumgartel, P. & DiMarzio, L.R. Bromocriptine therapy in cocaine withdrawal. Journal of Clinical Pharmacology, 1987, 27(4):267- 270.
19. Giannini, A.J. & Billet, W. Bromocriptine-desipramine protocol in the treatment of cocaine addiction. Journal of Clinical Pharmacology, 1987, 27(8):549-554.
20. Giannini, A.J., Folts, D.J., Feather, J.N. & Sullivan, B.S. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Research, 1989, 29(1):11-16.
21. Kumor, K., Sherer, M. & Jaffe, J. Effects of bromocriptine pretreatment on subjective and physiological responses to intravenous cocaine. Pharmacology, Biochemistry and Behavior, 1989, 33(4):829-837.
22. Tennant, F.S. & Sagherian, A.A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Archives of Internal Medicine, 1987, 147(1): 109-112.
23. Sitland-Marken, P.A., Wells, B.G., Froemming, J.H., Chu, C.C. & Brown, C.S. Psychiatric applications of bromocriptine therapy. Journal of Clinical Psychiatry, 1990, 51(2):68-82.
24. Teller, D.W. & Devenyi, P. Bromocriptine in cocaine withdrawal: Does it work? International Journal of Addictions, 1988, 23(11):1197-1205.
25. Roy, S.N., Bhattacharyya, A.K., Pradhan, S. & Pradhan, S.N. Behavioral and neurochemical effects of repeated administration of cocaine in rats. Neuropharmacology, 1978, 17:559-564.
26. Ho, B.T., Taylor, D.L. & Estevez, V.S. Behavioral effects of cocaine: Metabolic and neurochemical approach. In E.H. Ellinwood & M.M. Kilby (Eds.), Cocaine and Other Stimulants. New York: Plenum Publishing Corp., 1977.
27. Handelmann, L., Chordia, P.L., Escovar, I.L., Marion, I.J. & Lowen- son, J. Amantadine for treatment of cocaine dependence in methadone-maintained patients (letter). American Journal of Psychiatry, 1988, 145(4):533.
28. Handelmann, L., Lowenson, J., Marion, I. et al. Amantadine treatment of cocaine abuse. National Institute of Drug Abuse Research Monograph Series. 1988.
29. Morgan, C., Kosten, T., Gawin, F. & Kleber, H. Pilot trial of amantadine for ambulatory withdrawal from cocaine dependence. National Institute of Drug Abuse Research Monograph Series, 1988, 81:81-85.
30. Gawin, F.H., Morgan, C., Kosten, T.R. & Kleber, H.D. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology, 1989, 97(3):402-403.
31. Khatzian, E.J. Cocaine dependence: An extreme case and marked improvement with methylphenidate treatment. American Journal of Psychiatry, 1983, 140:784-785.
32. Khatzian, E.J., Gawin, F.H., Kleber, H.D. & Riordan, C. Methylphenidate treatment of cocaine dependence: A preliminary report. Journal of Substance Abuse Treatment, 1984, 107-112.
33. Crowley, T.J. Cautionary note on methylphenidate for cocaine dependence (letter). American Journal of Psychiatry, 1984, 141(2):327-328.
34. Gawin, F.H., Riordan, C. & Kleber, H.D. Methylphenidate use in non- ADD cocaine users: A negative study. American Journal of Drug and Alcohol Abuse, 1985, 11:193-197.
35. Gawin, F.H. & Kleber, H.D. Cocaine abuse treatment: Open pilot trial with desipramine and lithium carbonate. Archives of General Psychiatry, 1984, 41:903-909.
36. Dwoskin, L.P., Peris, J., Yasuda, R.P., Philpott, K. & Zahniser, N.R. Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine receptors to pergolide. Life Science, 1988, 42:255-262.
37. Koide, T. & Matshushita, H. An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment. Life Science, 1981, 28:1139-1145.
38. Banerjee, S.P., King, L.S., Riggi, S.J. & Chanda, S.K. Development of beta-adrenergic receptor subsensitivity by anti-depressants. Nature, 1977, 268:455-456.
39. Dewitt, H. & Wise, R.A. A blockade of cocaine reinforcement in rats with the dopamine blocker pimozide but not with the noradrenergic blockers phenolamine or phenoxybenzamine. Canadian Journal of Psychology, 1977, 31:195-203.
40. Tennant, F.S. & Rawson, R.A. Cocaine and amphetamine dependence treated with desipramine. National Institute of Drug Abuse Research Monograph Series, 1983, 43:351-355.
41. Kosten, R.T., Schumann, B., Wright, D., Carney, M.K. & Gawin, H. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. Journal of Clinical Psychiatry, 1987, 48: 442-444.
42. O’Brien, C.P., Childress, A.R., Arndt, I.A., McLellan, A.T., Woody, E. & Maany, I. Pharmacological and behavioral treatments of cocaine dependence: Controlled studies. Journal of Clinical Psychiatry, 1988, 49(2 suppl.), 17-22.
43. Gawin, F.H., Kleber, H.D., Byck, R., Rounsaville, B.J., Kosten, T.R., Jatlow, P.I. & Morgan, C. Desipramine facilitation of initial cocaine abstinence. Archives of General Psychiatry, 1989, 46:117-121.
44. Giannini, A.J., Malone, D.A., Giannini, M.C., Price, W.A. & Loiselle, R.H. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. Journal of Clinical Pharmacology, 1986, 26:211-214.
45. Huyghe, P. A cure for cocaine? New York Magazine, 1984, 74-84.
46. Rosecan, J. The treatment of cocaine abuse with imipramine, L-tyrosine, and L-tryptophan. Presented at World Congress of Psychiatry, Vienna, July 14-19, 1983.
47. Rowbotham, M., Jones, R.T., Benowitz, N. & Jacob, P. Trazodone- oral cocaine interactions. Archives of General Psychiatry, 1984, 41:895-899.
48. Small, G.W. & Purcell, J.J. Trazodone and cocaine abuse. Archives of General Psychiatry, 1985, 42:524.
49. Brotman, A.W., Witkie, S.M., Gelenberg, A.J., Falk, W.E., Wojcik, J. & Leahy, L. An open trial of maprotiline for the treatment of cocaine abuse: A pilot study. Journal of Clinical Pharmacology, 1988, 8(2):125-127.
50. Fishman, M.W. & Foltin, R.W. Interaction of desipramine maintenance with cocaine self-administration in humans. Abstracts of the 27th Annual Meeting of American College of Neuropsychopharmacology, 1988, December 11-16, San Juan, Puerto Rico.
51. Tennant, F.S. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. National Institute of Drug Abuse Research Monograph Series, 1984, 55: 159-163.
52. Tennant, F.S. & Tarver, A.L. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. National Institute of Drug Abuse Research Monograph Series, 1984, 55: 159-163.
53. Millman, R.B. Evaluation and clinical management of cocaine abusers. Journal of Clinical Pharmacology, 1988, 49(2 suppl.): 1988.
54. Owen, R.T. & Tyrer, P. Benzodiazepine dependence: A review of the evidence. Drugs, 1983, 25: 385-398.
55. Woody, G.E., O’Brien, C.P. & Greenstein, R. Misuse and abuse of diazepam: An increasingly common medical problem. International Journal of Addiction, 1975, 10:843-848.
56. Kosten, T.R. & Kleber, H.D. Sudden death in cocaine abusers: Relation to neuroleptic malignant syndrome? Lancet, 1987, 1:1198-1199.
57. Kosten, T.R. & Kleber, H.D. Rapid death during cocaine abuse: Variant of neuroleptic malignant syndrome? American Journal of Alcohol Abuse, 1988, 12:1-16.
58. Mittleman, R. & Wetli, C.V. Death.caused by recreational cocaine use. Journal of the American Medical Association, 1984, 252: 1889-1892.
59. Thierry, A.M., LeDouarin, C„& Penit, J. Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons in the activity of cells in the rat prefrontal cortex. Brain Research Bulletin, 1986, 16: 155-160.
60. Baldwin, R., Cranfield, R. & Swarbrick, D.J. A double-blind trial comparing single and divided daily doses of flupenthixol in the treatment of mild to moderately severe depression: A multicentre trial in general practice. Journal of Int. Biomet. Inform. Data, 1983, 4: 37-42.
61. Frolund, F. Treatment of depression in general practice: A controlled trial of flupenthixol. Current Medical Research Opin., 1974, 2:78-89.
62. Poldinger, W. & Sieberns, S. Depression-inducing and antidepressive effects of neuroleptics: Experiences with flupenthixol and flupenthixol decanoate. Neuropsychobiology, 1983, 10:131-136.
63. Robertson, M.M. & Trimble, M.R. Major tranquilizers used as antidepressants. Journal of Affective Disorders, 1982, 4: 173-195.
64. Wise, R. Neural mechanisms of the reinforcing action of cocaine. NIDA Research Monograph Series, Volume 50, 1984, U.S. Government Printing Office; Washington, D.C., pp. 15-53.
65. Gawin, F.H. Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology, 1986, 90: 142-143.
66. Scherer, M., Kumor, K. & Jaffe, J. Effects of intravenous cocaine are partially attenuated by haloperidol. Psych. Research, 1989.
67. Gawin, F.H. & Ellinwood, E.H. Cocaine and other stimulants —actions, abuse and treatment. New England Journal of Medicine, 1988, 318: 1173-1182.
68. Gawin, F.H., Allen, D. & Humblestone, B. Outpatient treatment of ‘crack’ cocaine smoking with flupenthixol decanoate: A preliminary report. Archives of General Psychiatry, 1989, 46(4):322-325.
69. Goddard, G.V., McIntyre, D.C. & Leach, C.K. A permanent change in brain functioning resulting from daily electrical stimulation. Experimental Neu- roloev. 1969. 25: 295.
70. Post, R.M. & Kopanda, R.T. Cocaine, kindling & psychosis. American Journal of Psychiatry, 1976, 133: 627-634.
71. Eidelberg, E., Lesse, H. & Gault, F.P. An experimental model of tem- peral lobe epilepsy: Studies of the convulsant properties of cocaine. In G.H. Glaser (ed.). EEG and Behavior, New York: Basic Books, 1963.
72. Ellinwood, E.H. & Kilbey, M.M. Chronic stimulant intoxication models of psychosis. In E. Hanlin & E. Usdin, Animal Models in Psychiatry and Neurology, New York: Pergamon Press, 1977.
73. Post, R.M., Kopanda, R.T. & Black, K.E. Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: Relationship to kindling and psychosis. Biological Psychiatry, 1976, 11: 403-419.
74. Halikas, J.A. & Kuhn, K.L. A possible neurophysiologial basis of cocaine craving. Annals of Clinical Psychiatry, 1990, 2(2): 79-83.
75. Halikas, J.A., Kemp, K.D., Kuhn, K.L., Carlson, G.A. & Crea, F.S. Carbamazepine for cocaine addiction? Letter to the editor. Lancet, 1989, March 18, 623-624.
76. Penry, J.K. & Daly, D.D. Complex and partial seizures and their treatment. In Advances in Neurology, Volume 11, 1975, New York: Raven Press.
77. Porter, R.J. & Penry, J.K. Efficacy in choice of anti-epileptic drugs. InMeinardi & A.J. Rowan (Eds.), Advances in Epileptology: Psychology, Pharmacotherapy and New Diagnostic Approaches, 1978, Amsterdam: Swets and Zeitlinger.
78. Ballenger, J.C. & Post, R.M. Therapeutic effects of carbamazepine in affective illness: A preliminary report. Clinical Psychopharmacology, 1978, 2: 159-175.
79. Post, R.M., Uhde, T.W. & Roy-Byrne, P.P. Correlates of antimanic responses to carbamazepine, 1987, Psychiatry Research, 1987, 21: 71-83.
80. Porter, R.J. & Theodore, W.H. Nonsedative regimens in the treatment of epilepsy. Archives of Internal Medicine, 1983, 143:945-947.
81. Callaghan, N., Kenny, R.A. & O’Neill, B. A prospective study between carbamazepine, phenytoin, and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. Journal of Neurol Neuro- surg Psychiatry, 1985, 48: 639-644.
82. Post, R.M. Time course of clinical effects of carbamazepine: Implication for mechanism of action. Journal of Clinical Psychiatry, 1988, 49 (suppl): 4, 35-46.
83. Keneko, S., Kurahashi, K., Mori, A., Hill, R.G. & Taberner, P.V. The mechanisms of actions of carbamazepine. In International Congress Series Abstracts of the 12 th World Congress of Neurology, 1981, Princeton: Excerpta Med- ica, 548: 318-319.
84. Kawalik, S., Levitt, M. & Barkai, A. Effects of carbamazepine and antidepressant drugs on endogenous catecholamine levels in the cerebroventricu- lar compartment of the rat. Psychopharmacology, 1984, 83: 169-171.
85. Purdy, R.E., Julien, R.M., Rairhust, A.S. & Terry, M.D. Effect of carbamazepine on the vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes. Epilepsia, 1977, 18: 251-257.
86. Olpe, H.R. & Jones, R.S. The action of anticonvulsant drugs on the firing of locus cereleus neurons: Selective, activating effect of carbamazepine. European Journal of Pharmacology, 1983, 91:107-110.
87. Pratt, J.A., Jenner, P., Johnson, A.L., Shorvon, S.D. & Reynolds, E.H. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: Implications for antiepileptic action and mental function. Journal of Neurol Neurosurg Psychiatry, 1984, 47:1131.
88. Consolo, S., Bianchi, S. & Ladinsky, H. Effect of carbamazepine on cholinergic parameters in rat brain areas. Neuropharmacology, 1976,15:653-657.
89. Halikas, J.A., Kuhn, K.L. & Maddux, T.L. Reduction of cocaine use among methadone maintenance patients using concurrent carbamazepine maintenance. Annals of Clinical Psychiatry, 1990, 2(1), 3-6.
90. Halikas, J.A., Crosby, R.D., Carlson, G.A., Crea, F.S., Graves, N.M. & Bowers, L.D. Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design. Clinical Pharmacology and Therapeutics, 1991, 50, in press.
91. Cushman, P. Effects of a cocaine epidemic on a population of methadone maintenance maintained drug abusers. Substance Abuse, 1988, 9(l):46-50.
92. Kosten, T.R., Gawin, F.H., Rounsaville, B.J., Kleber, H.D. Cocaine abuse among opioid addicts: Demographic and diagnostic factors in treatment. American Journal of Drug and Alcohol abuse, 1986, 12: 1-16, 1986.
93. Kosten, T.R, Rounsaville, B.J. & Kleber, H.D. A 2.5 year follow-up of cocaine use among treated opioid addicts: Have our treatments helped? Archives of General Psychiatry, 1987, 44: 281-284.
94. Kuhn, K.L., Halikas, J.A. & Kemp, K.D. Carbamazepine treatment of cocaine dependence in methadone maintenance patients with dual opiate-cocaine addiction. NIDA Research Monograph Series: Problems of Drug Dependence, 1989, 95: 316-317.
95. Kosten, R.T., Gawin, F. & Schumann, B. Treating cocaine abusing methadone maintenance patients with desipramine. NIDA Research Monograph Series, 1988, 81: 237-241.
96. Kosten, T.R., Kleber, H.D. & Morgan, C.H. Treatment of cocaine abuse with buprenorphine. Biological Psychiatry, 1989a, 26: 637-639.
97. Kosten, T.R., Kleber, H.D. & Morgan, C.H. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sciences, 1989b, 44(13):887-892.
98. Kosten, T.R. Buprenorphine detoxification from opioid dependence: A pilot study. Life Sciences, 1988, 42: 635-641.
99. Lewis, J.W. Buprenorphine. Drug and Alcohol Dependency, 1985, 14: 363-372.
100. Herridge, P. & Gold, M.S. Pharmacological adjuncts in the treatment of opioid and cocaine addicts. Journal of Psychoactive Drugs, 1988, 20(3): 233-242.
101. Gonzalez, J.P. & Brogden, R.N. Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 1988, 35(3): 192-213.
102. Taylor, D. & Ho, B.T. Neurochemical effects of cocaine following acute repeated injection. Journal of Neurosci. Research, 1977, 3: 95-101.